BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 32633805)

  • 1. Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review.
    Gertz MA; Dispenzieri A
    JAMA; 2020 Jul; 324(1):79-89. PubMed ID: 32633805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.
    Hasib Sidiqi M; Gertz MA
    Blood Cancer J; 2021 May; 11(5):90. PubMed ID: 33993188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2020 Jul; 95(7):848-860. PubMed ID: 32267020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloidosis in Heart Failure.
    Ihne S; Morbach C; Obici L; Palladini G; Störk S
    Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.
    Gertz MA
    Blood Cancer J; 2018 May; 8(5):44. PubMed ID: 29795248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary systemic amyloidosis.
    Comenzo RL
    Curr Treat Options Oncol; 2000 Apr; 1(1):83-9. PubMed ID: 12057064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Amyloidosis Treatment.
    Stern LK; Patel J
    Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Al amyloidosis.
    Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
    Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac amyloidosis: State of art in 2022].
    Oghina S; Delbarre MA; Poullot E; Belhadj K; Fanen P; Damy T
    Rev Med Interne; 2022 Sep; 43(9):537-544. PubMed ID: 35870985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis.
    Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A
    Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical clues for suspecting wild-type transthyretin cardiac amyloidosis in patients with monoclonal gammopathy of undetermined significance: a case report.
    Haga T; Okumura T; Harada Y; Hiraiwa H; Morimoto R; Kaneko S; Kato N; Shinoda M; Murohara T
    Egypt Heart J; 2024 Jun; 76(1):74. PubMed ID: 38856864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2024 Feb; 99(2):309-324. PubMed ID: 38095141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundamentals of Light Chain Cardiac Amyloidosis: A Focused Review.
    Latif A; Lateef N; Razzaq F; Kapoor V; Ahsan MJ; Ashfaq M; Iftikhar A; Anwer F; Holmberg M; William P
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(4):274-283. PubMed ID: 33256586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan.
    Shimazaki C; Hata H; Iida S; Ueda M; Katoh N; Sekijima Y; Ikeda S; Yazaki M; Fukushima W; Ando Y
    Intern Med; 2018 Jan; 57(2):181-187. PubMed ID: 29093404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.